These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31824620)

  • 1. Burden of Liver Diseases: A Review from Iran.
    Anushiravani A; Ghajarieh Sepanlou S
    Middle East J Dig Dis; 2019 Oct; 11(4):189-191. PubMed ID: 31824620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.
    Mohaghegh Shalmani H; Noori A; Shokoohi M; Khajavi A; Darvishi M; Delavari A; Jamshidi HR; Naderimagham S
    Arch Iran Med; 2015 Aug; 18(8):508-14. PubMed ID: 26265519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010.
    Malekzadeh F; Sepanlou SG; Poustchi H; Naghavi M; Forouzanfar MH; Shahraz S; Moradi-Lakeh M; Malekzadeh R
    Middle East J Dig Dis; 2015 Jul; 7():138-54. PubMed ID: 26396716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010.
    Sepanlou SG; Malekzadeh F; Naghavi M; Forouzanfar MH; Shahraz S; Moradi-Lakeh M; Malekzadeh R; Poustchi H
    Middle East J Dig Dis; 2015 Jul; 7():121-37. PubMed ID: 26396715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014.
    Saracco GM; Evangelista A; Fagoonee S; Ciccone G; Bugianesi E; Caviglia GP; Abate ML; Rizzetto M; Pellicano R; Smedile A
    World J Gastroenterol; 2016 Sep; 22(36):8187-93. PubMed ID: 27688660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of chronic hepatic disease in Portugal. Apropos of a review carried out in a hepatology unit].
    Valente AI; Almeida A; Gouveia A; Serejo F; Ramalho F; Baptista A; Saragoça A; Moura MC
    Acta Med Port; 1996; 9(7-9):197-202. PubMed ID: 9005696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.
    Hajarizadeh B; Razavi-Shearer D; Merat S; Alavian SM; Malekzadeh R; Razavi H
    Hepat Mon; 2016 Jul; 16(7):e37234. PubMed ID: 27642346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2017 M Balasegaram Memorial Lecture: The Changing Landscape of Liver Diseases in Malaysia-60 Years On!
    Goh KL
    Malays J Med Sci; 2019 Mar; 26(2):18-29. PubMed ID: 31447605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trend analysis on the disease burden related to cirrhosis and other chronic liver diseases caused by hepatitis B, in China, from 1990 to 2016].
    Zhang L; Fan ZF; Liu DW; Zhou MG; Wang ZQ; Li M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Feb; 41(2):173-177. PubMed ID: 32164125
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
    Meringer H; Shibolet O; Deutsch L
    World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms.
    Rác M; Skladaný Ľ
    Vnitr Lek; 2018; 64(7-8):735-741. PubMed ID: 30441981
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.